Influence of neoadjuvant radiotherapy combined with immunotherapy on minimally invasive surgeries for rectal cancer
Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 3
Abstract
The current domestic and international guidelines recommend neoadjuvant chemoradiation or total neoadjuvant therapy followed by radical surgery for mid-low locally advanced rectal cancer. In recent years, the significant efficacy of immune checkpoint inhibitors has been recognized for patients with microsatellite instability-high/mismatch repair deficiency. The latest researchs show that in the neoadjuvant therapy of microsatellite stability/mismatch repair proficient rectal cancers, combining immune checkpoint inhibitors with radiotherapy can also achieve significant tumor regression, which is expected to usher in a new era of neoadjuvant therapy for rectal cancer. Even so, surgery remains pivotal in the current multidisciplinary diagnosis and treatment modelity for rectal cancer. However, it can be foreseen that a more significant preoperative tumor regression will greatly promote the widespread use of minimally invasive surgery. The minimally invasive surgery for rectal cancer represented by transanal endoscopic microsurgery, transanal total mesorectal excision, laparoscopic total mesorectal excision plus removal of specimens through natural cavity is hopeful to be further promoted and become the standard surgery in the era of radiotherapy combined with immunotherapy for rectal cancer.
Authors and Affiliations
Yingchi YANG, Kai PANG, Zhongtao ZHANG
Keywords
Related Articles
- EP ID EP750870
- DOI 10.16139/j.1007-9610.2023.03.002
- Views 23
- Downloads 0
Exosomes research in pathophysiology of peritoneal metastatic gastric cancer
Practice of single-port and reduced-port laparoscopic gastric cancer surgery in China
The application and development of laparoscopic surgery for gastric cancer has experienced a history of more than two decades, from exploratory development to clinical validation, and then to large-scale clinical studies...
Interpretation of the 5th edition of WHO classification of endocrine and neuroendocrine tumors: update and progress on follicular cell-derived thyroid tumors
The 2022 WHO classification of endocrine and neuroendocrine tumors (5th edition) categorizes thyroid follicular cell-derived tumors into benign, low-risk, and malignant types. Benign tumors now include thyroid follicular...
Update of pathology in medullary thyroid carcinoma
Medullary thyroid carcinoma (MTC) is a rare thyroid malignancy, which is more aggressive with high metastasis and recurrence rate. Surgical treatment is the preferred treatment option for MTC. Targeted therapy and immuno...
Solitary cervical submental metastasis of papillary thyroid carcinoma: one case report
Solitary cervical submental nodule is a relatively rare case in clinical procedure and prone to miss diagnosis. Differential diagnosis with various head and neck diseases is necessary. This article reported a case of sol...